Find your next paid study

Idiopathic Subglottic Stenosis

~$75 – $2,000

Actual pay is set by the research site.

Mayo ClinicNCT06333652

Phase 3

Adjuvant Steroid Outcomes in Idiopathic Subglottic Stenosis

This study will examine the ability of steroid injections into the site of stenosis following surgical dilation to delay the need for repeated surgical dilatio…

Johns Hopkins UniversityNCT07228104

~$50 – $1,500

Actual pay is set by the research site.

Phase 1

Phase 1 Challenge Study Using rDEN2delta30-7169 to Evaluate Host-Pathogen Interactions in Primary, Homotypic, and Heterotypic Dengue Virus Infection

Background: Dengue is a viral disease spread by mosquitoes. Most people bitten by mosquitoes carrying dengue viruses do not get sick, but severe cases can cau…

Healthy VolunteersDengueHuman Challenge Trial

National Institute of Allergy and Infectious Diseases (NIAID)NCT07706686

~$500 – $6,750

Actual pay is set by the research site.

Dementia (Diagnosis)Mild Cognitive ImpairmentAlzheimer's Disease Dementia+1 more

Choose Myself (Before) Losing Myself: Providing Educational Information to Empower Alzheimer's Dementia Patients and Their Caregivers Utilizing Gamification Techniques Such as Choose Your Own Adventure.

The purpose of this study is to see if an educational interactive booklet about how dementia progresses throughout a person's life can be a helpful tool for pa…

The Cleveland ClinicNCT07846566

Actual pay is set by the research site.

A Prospective Long-Term Follow-Up Study to Evaluate the Use of the Minder Device to Aid in Treatment After Actionable Event Identification in Patients Diagnosed With Epilepsy.

The purpose of this research is to address the challenges of correctly monitoring, managing, and diagnosing epilepsy in participants whose seizures are not wel…

EpilepsyEpilepsy (Treatment Refractory)

Epiminder America, Inc.NCT07110454

~$10 – $1,050

Actual pay is set by the research site.

Phase 2

Phase II Randomized Study of Fianlimab Plus Cemiplimab Versus Cemiplimab Plus Placebo in First-Line Treatment of Participants With Recurrent or Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC) That Is Positive for PD-L1 Expression

This study is researching an experimental drug called fianlimab (also called REGN3767), combined with a medication called cemiplimab compared against cemiplima…

Head and Neck Squamous Cell Carcinoma (HNSCC)

Regeneron PharmaceuticalsNCT06769698

~$75 – $2,800

Actual pay is set by the research site.

Phase 1

A Phase I/IIa, Open-label, Multi-center Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of the ATR Kinase Inhibitor ART0380 Administered Orally as Monotherapy and in Combination to Patients With Advanced or Metastatic Solid Tumors

This clinical trial is evaluating a drug called ART0380 in participants with advanced or metastatic solid tumors. The main goals of this study are to: * Find …

Advanced CancerMetastatic CancerOvarian Cancer+6 more

Artios Pharma LtdNCT04657068

~$150 – $4,200

Actual pay is set by the research site.

WIM Exosuit Wearable Soft Robot for Enhancing Walking Activity

This study is to develop, test, and optimize a soft hip wearable robot for individuals with stroke, Parkinson's, multiple sclerosis, or older adults with no ne…

StrokeHealthy

Shirley Ryan AbilityLabNCT07061691

~$10 – $1,125

Actual pay is set by the research site.

ObesityOverweightInsulin Resistance

Improving Glycemic Control With Electrical Stimulation in Mexican-Americans

Once written consent is obtained, the participant will be provided with an accelerometer to be worn for 7 days to assess current physical activity levels. Subj…

University of Texas, El PasoNCT03947697

Actual pay is set by the research site.

Diabetic RetinopathyDiabetes Mellitus

Multicenter National Parallel Cluster Randomized Controlled Superiority Trial Comparing an Artificial Intelligence-Based Screening Strategy to Usual Care for Improving Eye-Care Follow-Up Among Patients With Diabetes (AI-BRIDGE Trial)

This pragmatic clinical trial is being conducted to test the effectiveness of AI-BRIDGE (Artificial Intelligence-Based point of caRe, Incorporating Diagnosis, …

University of Wisconsin, MadisonNCT06763952

Actual pay is set by the research site.

Phase 1

A 2-part Phase 1/2 Open-label Trial Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of ODM-212 in Combination With Anti-cancer Therapy in Participants With Advanced Solid Tumours

An open-label, multi-site, multi-cohort phase 1/2 trial to be conducted in 2 parts (dose escalation and dose expansion/optimisation)

MesotheliomaPancreatic CancerNSCLC (Advanced Non-small Cell Lung Cancer)

Orion Corporation, Orion PharmaNCT07563738

~$150 – $4,200

Actual pay is set by the research site.

EXtubation Related Complications - an International Observational Study To Understand the Impact and BEst Practices in the Operating Room and Intensive Care Unit - the EXTUBE Study

EXTUBE is an international, multicentre, prospective cohort study evaluating the incidence, risk factors, and outcomes of extubation-related complications and …

Extubation